Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial

Unknown author(s)

The Lancet · 2014 · 156 citations · 20 references

DOIFull text

Open access

Concepts

References

20